BOLD fMRI signal changes in preclinical Alzheimer’s disease
Stanislau Hrybouski, Sandhitsu R Das, Long Xie, Xueying Lyu, Laura EM Wisse, Melissa Kelley, Jacqueline Lane, Monica Sherin, Michael DiCalogero, Ilya M Nasrallah, John A Detre, Paul A Yushkevich, David A Wolk · 2025
Read BOLD fMRI signal changes in preclinical Alzheimer’s disease by Stanislau Hrybouski, Sandhitsu R Das, Long Xie, Xueying Lyu, Laura EM Wisse, Melissa Kelley, Jacqueline Lane, Monica Sherin, Michael DiCalogero, Ilya M Nasrallah, John A Detre, Paul A Yushkevich, David A Wolk (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712821.txt.
Description
Stanislau Hrybouski and thirteen co-authors measure BOLD fMRI signal changes at rest in preclinical Alzheimer disease. Changes in how the brain works can appear before symptoms, but how the amplitude of low frequency fluctuations relates to disease pathology was little studied. The medial temporal lobe, hit first and hardest by the disease, gets close study.
Data cover 224 people from a Penn cohort with structural and functional scans on a 3 tesla system. Amyloid scans cover all participants and tau scans cover 125. That size is reduced in amyloid positive people, both unimpaired and impaired, than in amyloid negative controls. Checks across the whole brain and in set regions adjust for age and sex. The signal change may serve as an early sign of change in how the brain works.
Catalog record
| CREATOR | Stanislau Hrybouski, Sandhitsu R Das, Long Xie, Xueying Lyu, Laura EM Wisse, Melissa Kelley, Jacqueline Lane, Monica Sherin, Michael DiCalogero, Ilya M Nasrallah, John A Detre, Paul A Yushkevich, David A Wolk |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |